Evidence map›Paper›PMID 28123037›Full record

ArticleNucleic acids research2017

sNASP and ASF1A function through both competitive and compatible modes of histone binding.

Andrew Bowman, Akiko Koide, Jay S Goodman, Meaghan E Colling, Daria Zinne, Shohei Koide, Andreas G Ladurner

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Histone Chaperone Network Is Highly Conserved inInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Interactions With Histone H3 & Tools to Study Them.Frontiers in cell and developmental biology · 2020
    Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Andrew BowmanBiomedical Center Munich, Physiological Chemistry, Faculty of Medicine, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152 Planegg-Martinsried, Germany a.bowman.1@warwick.ac.uk.
Akiko KoideDepartment of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637, USA.
Jay S GoodmanDepartment of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637, USA.
Meaghan E CollingBiomedical Center Munich, Physiological Chemistry, Faculty of Medicine, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152 Planegg-Martinsried, Germany.
Daria ZinneBiomedical Center Munich, Physiological Chemistry, Faculty of Medicine, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152 Planegg-Martinsried, Germany.
Shohei KoideDepartment of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637, USA.
Andreas G LadurnerBiomedical Center Munich, Physiological Chemistry, Faculty of Medicine, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152 Planegg-Martinsried, Germany andreas.ladurner@med.lmu.de.
Ludwig-Maximilians-Universität München · DEUniversity of Chicago · USMunich Cluster for Systems Neurology · DENYU Langone Health · US

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI MARK W. LINGEN · 1985 to 2026
$122.1M
Probing RAS-mediated Signaling with Monobody InhibitorsR01CA212608 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHOHEI KOIDE, John P O'Bryan · 2017 to 2026
$5.8M
Genetically encoded designer inhibitors for functional epigenomicsR01DA036887 · NIDA · UNIVERSITY OF CHICAGO · PI KOIDE, SHOHEI · 2013 to 2017
$2.0M
NCI NIH HHS P30 CA014599NCI NIH HHS R01 CA212608NIDA NIH HHS R01 DA036887Wellcome Trust WT105627MA
6 · The paper itself

Abstract

Histone chaperones are proteins that interact with histones to regulate the thermodynamic process of nucleosome assembly. sNASP and ASF1 are conserved histone chaperones that interact with histones H3 and H4 and are found in a multi-chaperoning complex in vivo Previously we identified a short peptide motif within H3 that binds to the TPR domain of sNASP with nanomolar affinity. Interestingly, this peptide motif is sequestered within the known ASF1-H3-H4 interface, raising the question of how these two proteins are found in complex together with histones when they share the same binding site. Here, we show that sNASP contains at least two additional histone interaction sites that, unlike the TPR-H3 peptide interaction, are compatible with ASF1A binding. These surfaces allow ASF1A to form a quaternary complex with both sNASP and H3-H4. Furthermore, we demonstrate that sNASP makes a specific complex with H3 on its own in vitro, but not with H4, suggesting that it could work upstream of ASF1A. Further, we show that sNASP and ASF1A are capable of folding an H3-H4 dimer in vitro under native conditions. These findings reveal a network of binding events that may promote the entry of histones H3 and H4 into the nucleosome assembly pathway.

Indexed as

Binding, CompetitiveBinding SitesCell Cycle ProteinsHistone ChaperonesHistonesModels, MolecularMultiprotein ComplexesNuclear ProteinsProtein BindingProtein ConformationProtein Interaction Domains and MotifsProtein MultimerizationCell Cycle ProteinsHistone ChaperonesHistonesMultiprotein ComplexesNuclear Proteins

Identifiers

PMID28123037
PMCPMC5314797
OpenAlexW2528248328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.